Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalence-Reference-Cited by-同舟云学术

Model-estimated impacts of pediatric respiratory syncytial virus prevention programs in Mali on asthma prevalence

Published:2023-05 Issue:2 Volume:2 Page:100092
ISSN:2772-8293
Container-title:Journal of Allergy and Clinical Immunology: Global
language:en
Short-container-title:Journal of Allergy and Clinical Immunology: Global

Author:

Ortiz Justin R.^ORCID,Laufer Rachel S.,Brunwasser Steven M.,Coulibaly Flanon,Diallo Fatoumata,Doumbia Moussa,Driscoll Amanda J.,Fell Deshayne B.,Haidara Fadima C.,Hartert Tina V.,Keita Adama M.,Neuzil Kathleen M.,Snyder Brittney M.,Sow Samba,Fitzpatrick Meagan C.

Funder

Bill and Melinda Gates Foundation

Pfizer

National Institutes of Health

PATH

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Reference27 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study;Shi;Lancet,2017

2. Respiratory syncytial virus vaccine research and development: World Health Organization technological roadmap and preferred product characteristics;Vekemans;Vaccine,2019

3. WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants—key considerations for global use;Sparrow;Vaccine,2022

4. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis;Li;Lancet,2022

5. Bringing preventive RSV monoclonal antibodies to infants in low- and middle-income countries: challenges and opportunities;Ananworanich,2021